TDOCTeladoc Health, Inc.

NYSE teladochealth.com


$ 12.77 $ -0.21 (-1.62 %)    

Friday, 03-May-2024 15:59:57 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 12.78
$ 13.30
$ 0.00 x 0
$ 0.00 x 0
$ 12.77 - $ 13.48
$ 12.53 - $ 30.41
6,206,900
na
2.14B
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-26-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-02-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-01-2021 09-30-2021 10-Q
12 08-02-2021 06-30-2021 10-Q
13 05-03-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-03-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-equal-weight-on-teladoc-health-lowers-price-target-to-15

Wells Fargo analyst Stephen Baxter maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 oppenheimer-maintains-outperform-on-teladoc-health-lowers-price-target-to-21

Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target fr...

 td-cowen-maintains-hold-on-teladoc-health-lowers-price-target-to-15

TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $16 to $15.

 evercore-isi-group-maintains-in-line-on-teladoc-health-lowers-price-target-to-14

Evercore ISI Group maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price target from $15 to $14.

 rbc-capital-maintains-outperform-on-teladoc-health-lowers-price-target-to-18

RBC Capital analyst Sean Dodge maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $25 t...

 stifel-maintains-hold-on-teladoc-health-lowers-price-target-to-16

Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $21 to $16.

 barclays-maintains-overweight-on-teladoc-health-lowers-price-target-to-20

Barclays analyst Steve Valiquette maintains Teladoc Health (NYSE:TDOC) with a Overweight and lowers the price target from $2...

 canaccord-genuity-maintains-buy-on-teladoc-health-lowers-price-target-to-25

Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $28...

 wall-street-futures-ride-high-on-microsoft-alphabet-cheer-but-will-inflation-data-burst-the-bubble-why-this-analyst-thinks-bull-run-isnt-over-yet

Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday.

 needham-reiterates-hold-on-teladoc-health

Needham analyst Ryan MacDonald reiterates Teladoc Health (NYSE:TDOC) with a Hold.

 teladoc-health-q1-2024-adj-eps-049-misses-046-estimate-sales-64610m-beat-63729m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46...

 stocks-drop-tech-tumbles-with-metas-weak-outlook-q1-stagflation-fears-gold-miners-advance-whats-driving-markets-thursday

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...

 us-stocks-brace-for-negative-start-amid-tech-earnings-disappointments-caution-ahead-of-data-worst-of-this-two-week-decline-is-behind-us-says-analyst

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platfor...

 can-magnificent-7-help-script-market-turnaround-earnings-pick-up-pace-with-microsoft-meta-alphabet-and-tesla-expected-this-week

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION